Chemical Compound Review:
CHEMBL619 3-methyl-7H-purine-2,6-dione
Synonyms:
SureCN237146, ACMC-1BT43, CCRIS 5817, AG-D-23350, SureCN8663339, ...
- Liver dysfunction markedly decreases the inhibition of cytochrome P450 1A2-mediated theophylline metabolism by fluvoxamine. Orlando, R., Padrini, R., Perazzi, M., De Martin, S., Piccoli, P., Palatini, P. Clin. Pharmacol. Ther. (2006)
- Distribution of xanthine oxidase and xanthine dehydrogenase specificity types among bacteria. Woolfolk, C.A., Downard, J.S. J. Bacteriol. (1977)
- Kidney toxicity of 3-methylxanthine in the rat. Sellman, R., Klemi, P.J. Journal of applied toxicology : JAT. (1984)
- Theophylline metabolism in healthy nonsmokers and in patients with insulin-dependent diabetes mellitus. Korrapati, M.R., Vestal, R.E., Loi, C.M. Clin. Pharmacol. Ther. (1995)
- The theophylline-enoxacin interaction: II. Changes in the disposition of theophylline and its metabolites during intermittent administration of enoxacin. Rogge, M.C., Solomon, W.R., Sedman, A.J., Welling, P.G., Koup, J.R., Wagner, J.G. Clin. Pharmacol. Ther. (1989)
- Cutaneous metabolism of theophylline by the human skin. Ademola, J.I., Wester, R.C., Maibach, H.I. J. Invest. Dermatol. (1992)
- In vivo, ex vivo, and in vitro effects of L-NAME and L-arginine on the metabolism of theophylline in the rabbit. Barakat, M., El-Kadi, A.O., Du Souich, P. Drug Metab. Dispos. (1997)
- The effect of RPR 102341 on theophylline metabolism and phenacetin O-deethylase activity in human liver microsomes. White, R.B., Heyn, H., Stevens, J.C. Pharm. Res. (1997)
- Circadian rhythms in theophylline disposition: simulations and observations in the dog. Rackley, R.J., Meyer, M.C., Straughn, A.B. Journal of pharmaceutical sciences. (1991)
- Phenotype-genotype analysis of CYP1A2 in Japanese patients receiving oral theophylline therapy. Takata, K., Saruwatari, J., Nakada, N., Nakagawa, M., Fukuda, K., Tanaka, F., Takenaka, S., Mihara, S., Marubayashi, T., Nakagawa, K. Eur. J. Clin. Pharmacol. (2006)
- The effect of increased caffeine intake on the metabolism and pharmacokinetics of theophylline in man. Monks, T.J., Lawrie, C.A., Caldwell, J. Biopharmaceutics & drug disposition. (1981)
- Determination of theophylline metabolites in human liver microsomes by high-performance liquid chromatography. Rasmussen, B.B., Nielsen, K.K., Brøsen, K. Anal. Biochem. (1994)
- Nonlinear metabolic disposition of theophylline. Dahlqvist, R., Billing, B., Miners, J.O., Birkett, D.J. Therapeutic drug monitoring. (1984)
- Comparative theobromine metabolism in five mammalian species. Miller, G.E., Radulovic, L.L., DeWit, R.H., Brabec, M.J., Tarka, S.M., Cornish, H.H. Drug Metab. Dispos. (1984)
- Lack of effect of terfenadine on theophylline pharmacokinetics and metabolism in normal subjects. Brion, N., Naline, E., Beaumont, D., Pays, M., Advenier, C. British journal of clinical pharmacology. (1989)
- Pharmacokinetics of theophylline and 3-methylxanthine in guinea pigs. I. Single dose administration. Madsen, S.M., Ribel, U. Acta pharmacologica et toxicologica. (1981)
- Complexes of poly(adenylic acid) with complementary monomers. Davies, R.J. Eur. J. Biochem. (1976)
- Theophylline disposition during acute and chronic hypoxia in the conscious dog. Saunier, C., du Souich, P., Hartemann, D., Sautegeau, A. Res. Commun. Chem. Pathol. Pharmacol. (1987)